Revenue of leading public RNA-based biotech companies worldwide 2023
收藏www.statista.com2025-01-21 收录
下载链接：
https://www.statista.com/statistics/1292552/revenue-of-top-rna-based-biopharma-companies-worldwide/
下载链接
链接失效反馈官方服务：
资源简介：
In 2020, Moderna reported around 803 million U.S. dollars of revenue, but two years after that the company made more than 19 billion U.S. dollars, mostly through its very successful COVID-19 vaccine named Spikevax. This statistic illustrates revenues of leading public RNA-based biotech companies worldwide in 2020, 2022, and 2023.
2020年，Moderna公司报告了约8.03亿美元的营收，然而两年之后，该公司营收超过190亿美元，这一成就主要得益于其极为成功的COVID-19疫苗——Spikevax。此统计数据展现了2020年、2022年及2023年全球主要上市RNA生物技术公司的营收状况。
提供机构：
Statista
